Dr. Herman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
270-05 76th Avenue
New Hyde Park, NY 11040Phone+1 718-470-7190
Summary
- Dr. Joseph Herman is a radiation oncologist in New Hyde Park, NY and is affiliated with Long Island Jewish Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 17 years. He specializes in gastrointestinal cancer, sarcoma, and clinical informatics and is experienced in pancreatic cancer.
Education & Training
- University of MichiganResidency, Radiation Oncology, 2000 - 2005
- University of MichiganInternship, Internal Medicine, 2000 - 2001
- University of Maryland School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2020 - 2026
- TX State Medical License 2017 - 2025
- MD State Medical License 2005 - 2018
- MI State Medical License 2000 - 2005
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy Start of enrollment: 2006 Nov 01
- A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer Start of enrollment: 2006 Dec 01
- Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereota...Colin S Hill, Rose Parkinson, Elizabeth M Jaffee, Elizabeth Sugar, Lei Zheng
International Journal of Radiation Oncology, Biology, Physics. 2024-11-14 - NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy.Nina N Sanford, Amol K Narang, Todd A Aguilera, Michael F Bassetti, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2024-11-05 - 1 citationsPostoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501).Rebecca A Snyder, Tyler J Zemla, Qian Shi, Diana Segovia, Syed A Ahmad
Annals of Surgical Oncology. 2024-10-01
Journal Articles
- Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant ChemotherapyAlex B Blair, Joseph Herman, Martin Makary, John L Cameron, Amol Narang, Daniel Laheru, Christopher Wolfgang, Matthew J Weiss, Ammar A Javed, Jin He, Journal of gastrointestinal surgery
- Performance/outcomes Data and Physician Process Challenges for Practical Big Data Efforts in Radiation OncologyAmy Moreno, Shruti Jolly, Mary Feng, Robert Miller, Joseph Herman, Martha M Matuszak, Clifton D Fuller, Wade Smith, James Hayman, Seungtaek Choi, Torunn I Yock, Peter ..., Medical Physics
Press Mentions
- Northwell Cancer Institute Appoints Oncology Experts to Lead New ProgramsJune 6th, 2020
- Before and After: My Pancreatic CancerAugust 8th, 2018
- Stereotactic Body Radiation Therapy (SBRT) for Select Pancreatic Cancer PatientsJune 7th, 2017
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/joseph-herman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: